Skip to main content
Premium Trial:

Request an Annual Quote

Jubilant Biosys, Schott Nexterion

Premium

Indian bioinformatics firm Jubilant Biosys announced that it has in-cluded Agilent’s Microarray 60mer Probe Identifiers in its PathArt signaling and metabolic pathways database.

PathArt contains over 900 signaling and metabolic pathways and covers nine physiologies and 17 disease states. According to the firm, users of the Agilent microarrays will be able to map and add biological relevance to the results of their experiments on PathArt.


Schott Nexterion, based in Duryea, Penn., has launched the Nexterion Slide MPX, a range of slides that allows the simultaneous conduction of multiple microarray experiments on a single slide. The product is comprised of coated glass substrates that are partitioned into individual wells and are delivered together with superstructures and sealing strips to avoid cross-contamination and excessive evaporation during hybridization. It is available in 16-well and 48-well formats.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.